Icecure Medical Ltd (ICCM)

$0.65

-0.09

(-11.73%)

Market is closed - opens 8 PM, 11 Nov 2024

Performance

  • $0.65
    $0.74
    $0.65
    downward going graph

    0.0%

    Downside

    Day's Volatility :12.28%

    Upside

    12.28%

    downward going graph
  • $0.48
    $1.57
    $0.65
    downward going graph

    26.15%

    Downside

    52 Weeks Volatility :69.43%

    Upside

    58.6%

    downward going graph

Returns

PeriodIcecure Medical LtdIndex (Russel 2000)
3 Months
7.24%
0.0%
6 Months
-42.71%
0.0%
1 Year
-14.91%
0.0%
3 Years
-90.48%
-26.0%

Highlights

Market Capitalization
41.1M
Book Value
$0.21
Earnings Per Share (EPS)
-0.29
Wall Street Target Price
3.2
Profit Margin
0.0%
Operating Margin TTM
-319.29%
Return On Assets TTM
-47.36%
Return On Equity TTM
-94.22%
Revenue TTM
3.3M
Revenue Per Share TTM
0.07
Quarterly Revenue Growth YOY
7.9%
Gross Profit TTM
1.4M
EBITDA
-14.1M
Diluted Eps TTM
-0.29
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.28
EPS Estimate Next Year
-0.25
EPS Estimate Current Quarter
-0.07
EPS Estimate Next Quarter
-0.07

Analyst Recommendation

Buy
    90%Buy
    10%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Icecure Medical Ltd(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 392.31%

Current $0.65
Target $3.20

Technicals Summary

Sell

Neutral

Buy

Icecure Medical Ltd is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Icecure Medical Ltd
Icecure Medical Ltd
14.56%
-42.71%
-14.91%
-90.48%
-94.01%
Stryker Corporation
Stryker Corporation
6.39%
13.73%
37.4%
38.7%
89.48%
Boston Scientific Corp.
Boston Scientific Corp.
2.38%
19.76%
71.16%
107.89%
119.69%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-2.97%
-23.63%
3.15%
-44.24%
-15.34%
Abbott Laboratories
Abbott Laboratories
0.84%
11.31%
24.07%
-8.79%
39.2%
Medtronic Plc
Medtronic Plc
-1.27%
5.89%
24.11%
-28.34%
-18.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Icecure Medical Ltd
Icecure Medical Ltd
NA
NA
NA
-0.28
-0.94
-0.47
NA
0.21
Stryker Corporation
Stryker Corporation
39.68
39.68
2.58
12.05
0.19
0.07
0.01
52.86
Boston Scientific Corp.
Boston Scientific Corp.
71.8
71.8
1.58
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
25.57
25.57
6.04
2.53
0.19
0.11
NA
16.18
Abbott Laboratories
Abbott Laboratories
35.48
35.48
2.28
4.67
0.15
0.06
0.02
22.94
Medtronic Plc
Medtronic Plc
30.24
30.24
1.66
5.2
0.08
0.04
0.03
37.39
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Icecure Medical Ltd
Icecure Medical Ltd
Buy
$41.1M
-94.01%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$141.0B
89.48%
39.68
16.34%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$128.0B
119.69%
71.8
11.26%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$39.1B
-15.34%
25.57
65.86%
Abbott Laboratories
Abbott Laboratories
Buy
$202.6B
39.2%
35.48
13.99%
Medtronic Plc
Medtronic Plc
Buy
$115.6B
-18.75%
30.24
12.06%

Insights on Icecure Medical Ltd

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 736.35K → 996.84K (in $), with an average increase of 26.1% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -3.57M → -3.03M (in $), with an average increase of 17.7% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 71.2% return, outperforming this stock by 86.1%

  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 107.9% return, outperforming this stock by 198.4%

Institutional Holdings

  • Citadel Advisors Llc

    0.31%
  • Renaissance Technologies Corp

    0.12%
  • Virtu Financial LLC

    0.05%
  • Two Sigma Investments LLC

    0.04%
  • Foundations Investment Advisors, LLC

    0.02%
  • Morgan Stanley - Brokerage Accounts

    0.01%

Company Information

Organization
Icecure Medical Ltd
Employees
71
CEO
Mr. Eyal Shamir
Industry
Miscellaneous

FAQs